CD22 and mixed phenotype acute leukemia: T-cell lineage assignment is specifically relying on cytoplasmic CD3 (cCD3) expression.The confirmation of B-cell component requires multiple markers, which is based on CD19 expression (CD20 is uncommon in MPAL), corroborating with one or two other B cell makers including CD79a, PAX5 or CD22.